Paediatric patients aged 2 years to <18 years at the time of informed consent
Subjects aged 16-70 may be enrolled into the osteosarcoma cohort.
Aged at least 2 months and less than 18-years-old on Day 1 AND
Aged ? 18 years.
Aged at least 18 years
Subjects must be aged between >= 18 years and =< 64 for AML and > 40 and =< 64 for ALL
Aged ? 18 years.
First relapsed participants aged less than (<) 60 years with first CR duration greater than (>) 1 year
Aged ? 18 years, voluntarily consented to the study.
Aged ? 18 years.
Men and women aged 18 years and over
Patients aged < 60 years who are unsuitable for standard induction therapy may be eligible after discussion with principal investigator (PI)
Aged =< 3 years at diagnosis (not age of transplant)
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min OR a serum creatinine based on age/gender as follows:            \r\n* =< 0.4 mg/dL (for patients aged 1 month to < 6 months)\r\n* =< 0.5 mg/dL (for patients aged 6 months to < 1 year)\r\n* =< 0.6 mg/dL (for patients aged 1 to < 2 years)\r\n* =< 0.8 mg/dL (for patients aged 2 to < 6 years)\r\n* =< 1 mg/dL (for patients aged 6 to < 10 years)\r\n* =< 1.2 mg/dL (for patients aged 10 to < 13 years)\r\n* =< 1.4 mg/dL (for female patients aged >= 13 years)\r\n* =< 1.5 mg/dL (for male patients aged 13 to < 16 years)\r\n* =< 1.7 mg/dL (for male patients aged >= 16 years)
Patients aged ?18 years at time of screening
Patients aged >= 50 and < 75 years (yrs) with CMML, or previously untreated MDS or MPD
Aged at least 18 years. Japan patients aged at least 20 years.
Aged at least 18 years
Aged at least 18 years.
Aged at least 18 years.
Aged at least 18 years. Patients from Japan aged at least 20 years.
Patients aged > 18
Aged ? 18 years.
Men and women aged ?18 years
Aged ? 18 years
Men aged 18 to 90 years with a histologic diagnosis of prostate cancer;
Aged at least 18 years.
CHILD: Children treated for ALL or AML or LL aged 5-12 years and their parents/caregivers
Women aged 18 and above;
Children aged 5-13 years of age will participate with a waiver of assent
INCLUSION CRITERIA FOR PARENTS: Parents of children who are aged 2-24 years
INCLUSION CRITERIA FOR PARENTS: Parents of children who has provided written informed consent (child aged 18 years and older), written assent (child aged 13-17 years), verbal assent (child aged 7-12 years)
INCLUSION CRITERIA FOR PATIENTS: Child aged 2-24 years
INCLUSION CRITERIA FOR PATIENTS: Child has provided written informed consent (child aged 18 years and older), written assent (child aged 13-17 years), verbal assent (child aged 7-12 years)
Patient aged 18-25 years: has signed informed consent for study participation
Availability of a donor aged ? 16 years and ? 75 years who is eligible according to local requirements and regulations
Adult (aged ? 18 years)
Aged 40-79
Subjects aged 18 years or more at the time of consent.
Aged at least 18